Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Medicamen Biotech is an Indian pharmaceutical company specializing in the development, manufacturing, and marketing of a wide range of generic formulations. The company operates state-of-the-art manufacturing facilities in Bhiwadi and Haridwar, with a significant strategic focus on the oncology segment through its dedicated cytotoxic drug facility. Its product portfolio spans multiple therapeutic areas, including cardiology, diabetology, and pain management, serving both domestic and international markets. Medicamen also provides contract manufacturing services to global pharmaceutical players, leveraging its WHO-GMP certified plants. The company is increasingly focused on high-value oncology products and expanding its presence in regulated markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Medicamen Biotech.